NEW YORK (GenomeWeb News) – MolecularMD today said that it has partnered with Ventana Medical Systems to study and compare methods of PTEN detection and expression.

PTEN is a tumor suppressor gene that is mutated in many cancers and is a regulator of the PI3-kinase pathway.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.